姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Chen,Guan-Han | Chairman | 2.04% | TAIWAN FIRST BIOTECHNOLOGY CORP. |
Chen,Jing-Ren | Vice Chairman | 1.22% | LE SHAN INVESTMENT CO., LTD. |
Chen,Guan-Zhou | Director | 4.20% | NICE ENTERPRISE CO., LTD. |
Liang,Huai-Xin | Director | 1.01% | FANG TIAN INDUSTRIAL CO., LTD. |
Xie,Xian-Jue | Director | 1.77% | YING JI LI INTERNATIONAL CONSULTING CONSULTANT CO., LTD. |
Chen,Zhi-Zhan | Director | 0.60% | CUNYUAN HEYE CO., LTD. |
Ceng,Yong-Fu | Independent Director | 0.00% | |
Wu,Yong-Qian | Independent Director | 0.00% | |
Chen,Wei-Long | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 1,184,580 | 5,115,585 | 4,900,038 |
Operating cost | 867,955 | 3,663,059 | 3,486,325 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 316,625 | 1,452,526 | 1,413,713 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 316,625 | 1,452,526 | 1,413,713 |
Operating expenses | 287,265 | 1,308,298 | 1,284,939 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 29,360 | 144,228 | 128,774 |
Non-operating income and expenses | -117,051 | 218,043 | 131,968 |
Net profit (loss) before tax | -87,691 | 362,271 | 260,742 |
Income tax expense (benefits) | 4,754 | 58,999 | 43,142 |
Net profit (loss) of ongoing business for the current period | -92,445 | 303,272 | 217,600 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | -92,445 | 303,272 | 217,600 |
Other comprehensive profit (loss), net | -291,418 | 592,349 | 38,104 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | -383,863 | 895,621 | 255,704 |
Net profit (loss) attributable to owners of parent company | -92,307 | 286,939 | 200,936 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | -138 | 16,333 | 16,664 |
Comprehensive profit (loss) attributable to owners of parent company | -373,767 | 857,259 | 246,897 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | -10,096 | 38,362 | 8,807 |
Basic earnings per share (yuan) | 0 | 0 | 0 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | -152,480 | 604,753 | 433,304 |
Net cash inflows (outflows) from investing activities | -41,144 | -133,880 | -208,126 |
Net cash inflow (outflow) from financing activities | 49,779 | -353,134 | -261,823 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -1,695 | 12,347 | 11,371 |
Increase (decrease) in cash and cash equivalents in the current period | -145,540 | 130,086 | -25,274 |
Beginning balance of cash and cash equivalents | 721,333 | 591,247 | 616,521 |
Ending balance of cash and cash equivalents | 575,793 | 721,333 | 591,247 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 2,518,286 | 2,775,178 | 2,597,921 |
Non-current asset | 11,770,248 | 12,092,818 | 11,423,789 |
Total asset | 14,288,534 | 14,867,996 | 14,021,710 |
Current liability | 2,707,191 | 3,039,709 | 2,644,278 |
Non-current liability | 3,816,696 | 3,496,807 | 3,812,941 |
Total liability | 6,523,887 | 6,536,516 | 6,457,219 |
share capital | 4,945,134 | 4,945,134 | 4,945,134 |
Equity - secruity token | - | - | - |
capital reserve | 268,144 | 268,144 | 268,144 |
retained earning | 1,070,668 | 1,345,945 | 1,165,584 |
Other equity | 700,041 | 981,501 | 420,448 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 6,983,987 | 7,540,724 | 6,799,310 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | 780,660 | 790,756 | 765,181 |
Total Equity | 7,764,647 | 8,331,480 | 7,564,491 |
Share capital awaiting retirement (unit: share) | 0 | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 14 | 15 | 13 |
日期 | 違反法規法條 | 罰鍰金額 |
---|---|---|
2023/11/07 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2023/08/04 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2023/01/01 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2022/06/01 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2017/06/03 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2017/06/03 | Paragraph 3, Article 12 of the Occupational Safety and Health Act | |
2017/06/03 | Paragraph 1, Article 6 of the Occupational Safety and Health Act |